MIST - Milestone Pharmaceuticals EPS beats by $0.03 May, 17 2021 07:37 AM Milestone Pharmaceuticals Inc. Milestone Pharmaceuticals (MIST): Q1 GAAP EPS of -$0.30 beats by $0.03.Cash, cash equivalents and short-term investments of $129.9M.Press Release For further details see: Milestone Pharmaceuticals EPS beats by $0.03